Dopamine transporters are phosphorylated on N-terminal serines in rat striatum - PubMed (original) (raw)
. 2002 Jul 12;277(28):25178-86.
doi: 10.1074/jbc.M200294200. Epub 2002 May 6.
Affiliations
- PMID: 11994276
- DOI: 10.1074/jbc.M200294200
Free article
Dopamine transporters are phosphorylated on N-terminal serines in rat striatum
James D Foster et al. J Biol Chem. 2002.
Free article
Abstract
Dopamine transporters (DATs) are neuronal phosphoproteins that clear dopamine from the synaptic cleft. Activation of protein kinase C (PKC) and inhibition of protein phosphatases by okadaic acid (OA) increase phosphorylation of DAT and lead to concomitant reduction in DAT activity and cell surface expression. Numerous potential sites for phosphorylation are present on DAT, but the sites utilized and their relationship to transport regulation are currently unknown. We used peptide mapping and epitope-specific immunoprecipitation to identify the region of DAT that undergoes phosphorylation in rat striatal tissue. Phosphoamino acid analysis revealed that basal and stimulated samples were phosphorylated primarily on serine. Digestion of (32)PO(4)-labeled DAT with trypsin and immunoprecipitation with N- or C-terminal specific antisera failed to isolate phosphopeptide fragments corresponding to photoaffinity-labeled fragments that contain all internal interhelical loops. However, digestion of (32)PO(4)-labeled DAT with endoproteinase asp-N and immunoprecipitation with an N-terminal antiserum extracted two phosphopeptide fragments from both basal and PKC/OA-stimulated samples, demonstrating that the N-terminal cytoplasmic tail is a major site of phosphorylation. Aminopeptidase treatment of PKC- and/or OA-stimulated DAT cleaved essentially all (32)PO(4) label without proteolysis extending past transmembrane domains 1 and 2, providing further evidence that most phosphorylation sites are near the N terminus and not in intracellular loops or C-terminal domains. In situ proteolysis of the N-terminal tail indicates that the majority of stimulated phosphorylation sites are N-terminal to an antibody epitope at residues 42-59. Two-dimensional analysis of purified protein produced three tryptic phosphopeptides that may result from phosphorylation of multiple sites, but the fragments did not co-migrate with synthetic tryptic peptides phosphorylated at serines 2 and 4. These results indicate that most or all of the basal and stimulated phosphorylation of DAT in striatal tissue occurs on one or more residues in a group of six serines clustered near the distal end of the cytoplasmic N terminus.
Similar articles
- Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis.
Vaughan RA, Kuhar MJ. Vaughan RA, et al. J Biol Chem. 1996 Aug 30;271(35):21672-80. doi: 10.1074/jbc.271.35.21672. J Biol Chem. 1996. PMID: 8702957 - Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1.
Foster JD, Pananusorn B, Cervinski MA, Holden HE, Vaughan RA. Foster JD, et al. Brain Res Mol Brain Res. 2003 Jan 31;110(1):100-8. doi: 10.1016/s0169-328x(02)00645-9. Brain Res Mol Brain Res. 2003. PMID: 12573538 - Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.
Moritz AE, Foster JD, Gorentla BK, Mazei-Robison MS, Yang JW, Sitte HH, Blakely RD, Vaughan RA. Moritz AE, et al. J Biol Chem. 2013 Jan 4;288(1):20-32. doi: 10.1074/jbc.M112.407874. Epub 2012 Nov 16. J Biol Chem. 2013. PMID: 23161550 Free PMC article. - Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.
Vaughan RA, Huff RA, Uhl GR, Kuhar MJ. Vaughan RA, et al. J Biol Chem. 1997 Jun 13;272(24):15541-6. doi: 10.1074/jbc.272.24.15541. J Biol Chem. 1997. PMID: 9182590 - Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains.
Vaughan RA, Gaffaney JD, Lever JR, Reith ME, Dutta AK. Vaughan RA, et al. Mol Pharmacol. 2001 May;59(5):1157-64. doi: 10.1124/mol.59.5.1157. Mol Pharmacol. 2001. PMID: 11306699
Cited by
- Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
Rickhag M, Owens WA, Winkler MT, Strandfelt KN, Rathje M, Sørensen G, Andresen B, Madsen KL, Jørgensen TN, Wörtwein G, Woldbye DPD, Sitte H, Daws LC, Gether U. Rickhag M, et al. J Biol Chem. 2013 Sep 20;288(38):27534-27544. doi: 10.1074/jbc.M112.441295. Epub 2013 Jul 24. J Biol Chem. 2013. PMID: 23884410 Free PMC article. - Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice.
Hayashizaki S, Hirai S, Ito Y, Honda Y, Arime Y, Sora I, Okado H, Kodama T, Takada M. Hayashizaki S, et al. PLoS One. 2013 Oct 14;8(10):e75975. doi: 10.1371/journal.pone.0075975. eCollection 2013. PLoS One. 2013. PMID: 24155877 Free PMC article. - SLC6 transporters: structure, function, regulation, disease association and therapeutics.
Pramod AB, Foster J, Carvelli L, Henry LK. Pramod AB, et al. Mol Aspects Med. 2013 Apr-Jun;34(2-3):197-219. doi: 10.1016/j.mam.2012.07.002. Mol Aspects Med. 2013. PMID: 23506866 Free PMC article. Review. - Development of a peptide targeting dopamine transporter to improve ADHD-like deficits.
Lai TKY, Su P, Zhang H, Liu F. Lai TKY, et al. Mol Brain. 2018 Nov 9;11(1):66. doi: 10.1186/s13041-018-0409-0. Mol Brain. 2018. PMID: 30413217 Free PMC article. - Adenosine A2A Receptor Blockade Ameliorates Mania Like Symptoms in Rats: Signaling to PKC-α and Akt/GSK-3β/β-Catenin.
Shalaby HN, Zaki HF, Ain-Shoka AAA, Mohammed RA. Shalaby HN, et al. Mol Neurobiol. 2022 Oct;59(10):6397-6410. doi: 10.1007/s12035-022-02977-2. Epub 2022 Aug 9. Mol Neurobiol. 2022. PMID: 35943710 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous